Wainzua (Eplontersen) Recommended for Approval in the EU by Chmp for the Treatment of Adults With Polyneuropathy Associated With Hereditary Transthyretin-Mediated Amyloidosis

THOMSON REUTERS
21 Oct 2024

Wainzua (Eplontersen) Recommended for Approval in the EU by Chmp for the Treatment of Adults With Polyneuropathy Associated With Hereditary Transthyretin-Mediated Amyloidosis

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10